FDA Weighs Tighter Standards For Blood Glucose Meters At Public Meeting
This article was originally published in The Gray Sheet
Executive Summary
FDA will likely tighten standards for market clearance and CLIA waivers of home-use blood glucose meters, which are also frequently used in hospital settings, agency officials indicated at a March 16-17 public meeting on the topic in Gaithersburg, Md
You may also be interested in...
Blood Glucose Meter Accuracy Problems Acknowledged By FDA, Industry And Clinicians
Certain 510(k)-cleared blood glucose meters do not perform at the regulatory standards for which they were cleared after they hit the market, stakeholders agree. FDA is working on the matter, but no clear plan of action was laid out at a Diabetes Technology Society meeting last week.
FDA Holds Up Edwards-DexCom Continuous Glucose Monitor For Hospital Use
Edwards Lifesciences' and DexComs’ first-of-its-kind continuous glucose monitor for hospital use is running into delays at FDA.
FDA Holds Up Edwards-DexCom Continuous Glucose Monitor For Hospital Use
Edwards Lifesciences' and DexComs’ first-of-its-kind continuous glucose monitor for hospital use is running into delays at FDA.